Back

Prognostic utility of the GLIS model for sarcopenia in older patients with heart failure: a post-hoc analysis of the FRAGILE-HF study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Sport exercise rehabilitation (4) Physical Inactivity ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Taisuke Nakade

Juntendo University Graduate School of Medicine, Tokyo (Japan)

5 More presentations in this session

Presentation thumbnail
Long-term exposure to outdoor fine particulate matter may attenuate the association of physical activity with mortality and cardiovascular events
Mr J. Hao (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Heart rate vigor score: an analysis of supramaximal heart rate mortality outcomes based on heart rate vigor assessment
Doctor P. Patel (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Sex differences in mental health, independence, quality of life, and aerobic endurance throughout exercise-based cardiac rehabilitation
Ms H. Brito Da Silva (Davos Wolfgang, CH)
Abstract Slides Video
Presentation thumbnail
Individualised aerobic and resistance exercise training improves exercise tolerance in individuals with Long COVID: findings from the PERCEIVE randomised controlled trial
Mr J. Smith (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Iron deficiency and exercise capacity in patients after myocardial infarction attending cardiac rehabilitation program
Mr M. Zavrtanik (Ljubljana, SI)
Abstract Slides Video

Access the full session

Session thumbnail
Sport exercise rehabilitation (4)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Impact of sarcopenia and osteopenia on prognosis in elderly heart failure patients: a computed tomography-based comparative study
thumbnail
Congress Session
Cardiovascular risk and advancing age
thumbnail
Congress Presentation
Fat free mass index predicted clinical outcomes in patients with heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources